Human Papillomavirus 16 (HPV 16) and HPV 18 Antibody Responses Measured by Pseudovirus Neutralization and Competitive Luminex Assays in a Two- versus Three-Dose HPV Vaccine Trial

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses in a 2- versus 3-dose HPV vaccine (Gardasil) trial were measured by a pseudovirus neutralizing antibody (PsV NAb) assay and by the Merck competitive Luminex immunoassay (cLIA). Eight hundred twenty-four female subjects assigned to three...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Krajden, Mel, Cook, Darrel, Yu, Amanda, Chow, Ron, Mei, Wendy, McNeil, Shelly, Money, Deborah, Dionne, Marc, Karunakaran, Karuna P., Palefsky, Joel M., Dobson, Simon, Ogilvie, Gina, Petric, Martin
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2011
Materias:
Vaccine Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3067374/
https://ncbi.nlm.nih.gov/pubmed/21248158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00489-10
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares